cholesterol inhibitor [phsu]
Absorption [npop]
Japanese [popg]
Type 2 [clas]
Diabetes [dsyn]
Patients [podg]
Dyslipidaemia [dsyn]
cholesterol absorption [celf]
Suggest [idcn]
Independent [idcn]
cardiovascular events [fndg]
Study [mnob]
Efficacy [qlco]
ezetimibe [orch, phsu]
Japanese [popg]
Patients [podg]
Diabetes Mellitus, Type 2 [dsyn]
Complicated [ftcn]
Dyslipidaemia [dsyn]
Increased [qnco]
cholesterol absorption [celf]
Reported [inpr]
Subject [grup]
Methods [inpr]
Six [qnco]
Patients [podg]
Type 2 Diabetes [dsyn]
Complicated [ftcn]
Dyslipidaemia [dsyn]
Received [qlco]
ezetimibe [orch, phsu]
mg day [qnco]
weeks [tmco]
Lipid [lipd]
Profile [lbpr]
cholesterol synthesis [moft]
Marker [clna]
lathosterol [strd]
cholesterol absorption [celf]
Marker [clna]
Cholestanol [bacs, strd]
sitosterol [phsu, strd]
campesterol [strd]
Measured [qlco]
therapy [ftcn]
Evaluate [ftcn]
Efficacy [qlco]
ezetimibe [orch, phsu]
serum low density lipoprotein [lbpr]
Cholesterol [bacs, strd]
cholesterol absorption [celf]
Marker [clna]
cholesterol synthesis [moft]
Marker [clna]
Suggest [idcn]
serum LDL [lbpr]
cholesterol absorption [celf]
synthesis [biof]
ezetimibe [orch, phsu]
treatment [ftcn]
cholesterol absorption [celf]
Marker [clna]
Decreased [qnco]
serum lipid [lbpr]
Profile [lbpr]
Including [ftcn]
Improved [qlco]
lowering [spco]
Patients [podg]
Receive [qlco]
Statin [orch, phsu]
therapy [ftcn]
newly [idcn]
Started [qlco]
ezetimibe [orch, phsu]
ezetimibe [orch, phsu]
Group [idcn]
P NOS [aapp, imft]
Conclusions [idcn]
Suggest [idcn]
ezetimibe [orch, phsu]
Lipid [lipd]
Profile [lbpr]
Japanese [popg]
Type 2 Diabetes [dsyn]
Patients [podg]
Dyslipidaemia [dsyn]
reduction [npop]
cholesterol absorption [celf]
